Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

WAVE Life Sciences Ltd diskutieren

WAVE Life Sciences Ltd

WKN: A1436W / Symbol: WVE / Name: WAVE Life / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

5,15 €
-1,21 %

Buy WAVE Life Sciences Ltd

Einschätzung Buy
Rendite (%) 62,83 %
Kursziel 7,35
Veränderung
Endet am 23.03.24

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 11,06 %
Kursziel 11,91
Veränderung
Endet am 17.04.24

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $13.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 45,71 %
Kursziel 6,42
Veränderung
Endet am 05.07.24

Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Raymond James. They set an "outperform" rating and a $7.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,04 %
Kursziel 7,26
Veränderung
Endet am 04.08.24

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for WVE provided by MarketBeat

Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,67 %
Kursziel 10,94
Veränderung
Endet am 19.12.24

Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $12.00 price target on the stock, up previously from $5.00.
Ratings data for WVE provided by MarketBeat

Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Leerink Partnrs from a "market perform" rating to an "outperform" rating.
Ratings data for WVE provided by MarketBeat

Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,65 %
Kursziel 15,77
Veränderung
Endet am 01.04.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $17.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 15,99 %
Kursziel 17,73
Veränderung
Endet am 25.06.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "outperform" rating re-affirmed by analysts at Mizuho. They now have a $19.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 20,89 %
Kursziel 14,05
Veränderung
Endet am 26.06.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for WVE provided by MarketBeat